Key points are not available for this paper at this time.
Sevoflurane is a widely used volatile anesthetic in clinical treatment. Recently, the effect of sevoflurane on tumor cell signaling pathways has attracted the attention of many researchers in the field. However, the underlying mechanism behind the effect of sevoflurane on tumor cell signaling pathways still remains unclear. Based on the evidence of in vitro experiments, this paper reviews the recent research results on the sevoflurane-mediated regulation on solid tumors and presents its potential molecular mechanisms that can provide references for clinical practices.
Ouyang et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: